Literature DB >> 27776215

Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.

Zheyu Shen1,2, Aiguo Wu1, Xiaoyuan Chen2.   

Abstract

Magnetic iron oxide nanoparticles (MIONs) have attracted enormous attention due to their wide applications, including for magnetic separation, for magnetic hyperthermia, and as contrast agents for magnetic resonance imaging (MRI). This review article introduces the methods of synthesizing MIONs, and their application as MRI contrast agents. Currently, many methods have been reported for the synthesis of MIONs. Herein, we only focus on the liquid-based synthesis methods including aqueous phase methods and organic phase methods. In addition, the MIONs larger than 10 nm can be used as negative contrast agents and the recently emerged extremely small MIONs (ES-MIONs) smaller than 5 nm are potential positive contrast agents. In this review, we focus on the ES-MIONs because ES-MIONs avoid the disadvantages of MION-based T2- and gadolinium chelate-based T1-weighted contrast agents.

Entities:  

Keywords:  contrast agents; extremely small MIONs (ES-MIONs); magnetic iron oxide nanoparticles (MIONs); magnetic resonance imaging (MRI); synthesis methods

Mesh:

Substances:

Year:  2016        PMID: 27776215     DOI: 10.1021/acs.molpharmaceut.6b00839

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  53 in total

1.  Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma.

Authors:  Zheyu Shen; Ting Liu; Zhen Yang; Zijian Zhou; Wei Tang; Wenpei Fan; Yijing Liu; Jing Mu; Ling Li; Vladimir I Bregadze; Swadhin K Mandal; Anna A Druzina; Zhenni Wei; Xiaozhong Qiu; Aiguo Wu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2020-01-13       Impact factor: 12.479

Review 2.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

Review 3.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

4.  Multimodal assessment of SERS nanoparticle biodistribution post ingestion reveals new potential for clinical translation of Raman imaging.

Authors:  Jos L Campbell; Elliott D SoRelle; Ohad Ilovich; Orly Liba; Michelle L James; Zhen Qiu; Valerie Perez; Carmel T Chan; Adam de la Zerda; Cristina Zavaleta
Journal:  Biomaterials       Date:  2017-04-28       Impact factor: 12.479

5.  Gadolinium Deposition Safety: Seeking the Patient's Perspective.

Authors:  C A Mallio; C C Quattrocchi; À Rovira; P M Parizel
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

Review 6.  Membrane-core nanoparticles for cancer nanomedicine.

Authors:  Jianfeng Guo; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-22       Impact factor: 15.470

Review 7.  Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease.

Authors:  Mallika Modak; Molly A Frey; Sijia Yi; Yugang Liu; Evan A Scott
Journal:  Curr Opin Biotechnol       Date:  2020-07-15       Impact factor: 9.740

Review 8.  Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

Authors:  Joel Garcia; Stephen Z Liu; Angelique Y Louie
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2017-11-28       Impact factor: 4.226

Review 9.  Magnetic nanoformulations for prostate cancer.

Authors:  Pallabita Chowdhury; Allison M Roberts; Sheema Khan; Bilal B Hafeez; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  Drug Discov Today       Date:  2017-05-16       Impact factor: 7.851

10.  Dotted Core-Shell Nanoparticles for T1 -Weighted MRI of Tumors.

Authors:  Zheyu Shen; Jibin Song; Zijian Zhou; Bryant C Yung; Maria A Aronova; Yan Li; Yunlu Dai; Wenpei Fan; Yijing Liu; Zihou Li; Huimin Ruan; Richard D Leapman; Lisen Lin; Gang Niu; Xiaoyuan Chen; Aiguo Wu
Journal:  Adv Mater       Date:  2018-07-04       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.